Evidence map›Paper›PMID 35620254›Full record

ArticleClinical case reports2022

Pure Sertoli cell tumor of the ovary: A case report.

Suraj Shrestha, Sushan Homagain, Suraj Bhatta, Sansar Babu Tiwari, Rishikesh Rijal, Roshan Aryal, Nisha Sharma, Pooja Paudyal, Neeta Katuwal, Suniti Joshi Rawal

Open access · goldAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Clinical case reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.9field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Suraj ShresthaMaharajgunj Medical Campus Institute of Medicine Maharajgunj Nepal.ORCID https://orcid.org/0000-0001-6888-260X
Sushan HomagainMaharajgunj Medical Campus Institute of Medicine Maharajgunj Nepal.
Suraj BhattaMaharajgunj Medical Campus Institute of Medicine Maharajgunj Nepal.
Sansar Babu TiwariDepartment of Pathology Tribhuvan University Teaching Hospital Maharajgunj Nepal.ORCID https://orcid.org/0000-0002-6900-9383
Rishikesh RijalMaharajgunj Medical Campus Institute of Medicine Maharajgunj Nepal.
Roshan AryalMaharajgunj Medical Campus Institute of Medicine Maharajgunj Nepal.ORCID https://orcid.org/0000-0002-4689-9264
Nisha SharmaDepartment of Pathology Tribhuvan University Teaching Hospital Maharajgunj Nepal.
Pooja PaudyalDepartment of Obstetrics and Gynecology Tribhuvan University Teaching Hospital Maharajgunj Nepal.
Neeta KatuwalDepartment of Obstetrics and Gynecology Tribhuvan University Teaching Hospital Maharajgunj Nepal.
Suniti Joshi RawalDepartment of Obstetrics and Gynecology Tribhuvan University Teaching Hospital Maharajgunj Nepal.
Tribhuvan University Teaching Hospital · NP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Pure Sertoli cell tumors are an uncommon variant of rare ovarian Sertoli-Leydig cell tumors. Due to nonspecific clinical and imaging features, diagnosis is often made after histopathological examination. The prognosis is excellent as most are detected in the early stages and surgical resection is often curative in most cases.

Indexed as

ovarian tumorSertoli cell tumorSertoli‐Leydig cell tumor

Identifiers

PMID35620254
PMCPMC9127247
OpenAlexW4281385761

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.